相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Dinesh Khanna et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Management of systemic sclerosis-associated interstitial lung disease
David Roofeh et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Anna-Maria Hoffmann-Vold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
Elizabeth R. Volkmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Diagnosis of pulmonary hypertension
Adaani Frost et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Geetabali Sircar et al.
RHEUMATOLOGY (2018)
Screening high-resolution computed tomography of the chest to detect interstitial lung disease in systemic sclerosis: a global survey of rheumatologists
Elana J. Bernstein et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Haematopoietic stem cell transplantation in systemic sclerosis
Ulrich A. Walker et al.
RMD OPEN (2018)
The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
Leona M. Dowman et al.
THORAX (2017)
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
Nicole S. Goh et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Evaluation and management approaches for scleroderma lung disease
Sara R. Schoenfeld et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2017)
Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment
Hyun J. Kim et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?
Michele Iudici et al.
AUTOIMMUNITY REVIEWS (2015)
Interstitial Lung Disease in Systemic Sclerosis
Athol U. Wells et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
Owen A. Moore et al.
RHEUMATOLOGY (2013)
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
Dinesh Khanna et al.
CURRENT RHEUMATOLOGY REVIEWS (2010)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
分享论文
